Role Oxidative stress in formation Of kidney stones

Main Article Content

Sabah H. khurshid
Sherko M. Sharif

Abstract

The study includes (90) people of males and females, whom (30) healthy peoples (16 males, 14 females) and (60) patients have kidney stones (33 males, 27 females) that aged ranged from (20 – 62) years.


The study was conducted to evaluated (MDA, SOD, Catalase ,total concentration of thiols, total concentration of protein and albumin) in blood serum of kidney stone patients. Also evaluated level of TAC, MDA, and Biochemical test (uric acid and Calcium) for 24 hours urine collection.


 The study showed significantly increase concentration of (MDA) that value in the serum of patients (48.813±6.614nmol/l) compared with control groups (17.689±4.176 nmol/l) in addition to significantly decrease in the level of (SOD, Catalase, total thiols, total proteins and albumin) in blood serum of patients, They were (39.46±6.95 U/ml), (293.5±26.08KU\l), (223.9±18.39µmol/ml), (6.584±0.532g\dl), (3.325±0.29 mg/dl) compared with control (64.52±8.42 U/ml), (509.01±43.41 KU\l), (401.36±37.42 µmol/ml), (8.500±0.321 g\dl), (4.5173±0.26 mg/dl) respectively at the level of probability (P ≤ 0.05)


The study also showed the presence of a significantly increase concentration of MDA, Uric acid, Calcium of urine patients they were (166.0±8.103nmol/l), (14.27±1.511mg/dl), (9.126±1.731mg/dl) comparing with controlling group which were (88.62±6.002 nmol/l), (6.671±0.561 mg/dl(, (6.946±0.904 mg/dl) respectively, the significantly decrease of the level of total anti-Oxidants in the urine of patients of urinary stones (45.90±8.063 µmol\l) compared with controlling group (98.0±12.757µmol\l) ,The highest incidence of urinary tract stones in the age group (31- 40) years and that the high percentage prevalence of kidney stones in male group (55%) compared with a female groups (45%).

Article Details

How to Cite
Sabah H. khurshid, & Sherko M. Sharif. (2023). Role Oxidative stress in formation Of kidney stones. Tikrit Journal of Pure Science, 22(7), 94–102. https://doi.org/10.25130/tjps.v22i7.838
Section
Articles

References

1- Schulsinger, D. A. (Ed.). (2014). Kidney Stone Disease: Say NO to Stones!. Springer. 2- Moran, M. E. (2014). A History of Histories. In Urolithiasis (pp. 1-3). Springer New York. 3- Parker, J. N., & Parker, P. M. (2002). The Official Patient's Sourcebook on Peyronie's Disease. 4- Aggarwal, K. P., Narula, S., Kakkar, M., & Tandon, C. (2013). Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. BioMed research international, 2013. 5- Tamošaitytė, S., Hendrixson, V., Ţelvys, A., Tyla, R., Kučinskienė, Z. A., Jankevičius, F., ... & Šablinskas, V. (2013). Combined studies of chemical composition of urine sediments and kidney stones by means of infrared microspectroscopy. Journal of biomedical optics, 18(2), 027011-027011. 6- Armstrong, D. (2015). Preface. Advanced protocols in oxidative stress III.Methods in molecular biology (Clifton, NJ), 1208, v.

7- Jakob, U., & Reichmann, D. (2013). Oxidative Stress and Redox Regulation(pp. 1-42). Dordrecht, The Netherlands: Springer. 8-Shahidi, F. (Ed.). (2015). Handbook of Antioxidants for Food Preservation. Woodhead Publishing. 9-Armstrong, D. (2015). Advanced Protocols in Oxidative Stress III. Methods in Molecular Biology. 10- Del Rio, D., Stewart, A. J., & Pellegrini, N. (2005). A review of recent studies on malondialdehyde as toxic molecule and biological

marker of oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases, 15(4), 316-328. 11- Balat, A., Resic, H., Bellinghieri, G.,& Anarat, A. (2012). Devil’s Triangle in Kidney Diseases: Oxidative Stress, Mediators, and Inflammation. International journal of nephrology, 2012. 12- Miller, J., Le Prell, C. G., & Rybak, L. (2015). Free Radicals in ENT Pathology. Oxidative Stress in Applied Basic Research and Clinical Practice. 13- Laher, I. (Ed.). (2014). Systems Biology of Free Radicals and Antioxidants. Springer. 14- Korotkova, I. V., Nikolaeva, M.A., Bozhedomov, V. A., Golubeva, E. L., Krutskikh, A. Y., Ter-Avanesov, G. V., & Sukhikh, G. T. (2001). Free radical generation in ejaculate samples from infertile patients. Bulletin of experimental biology and medicine, 131(6), 555-557. 15- Silva, F. Moreira da, Marques, A. and Chaveiro, A. Reactive Oxygen Species: A Double-Edged Sword in Reproduction. Angra do Heroísmo, Portugal : The Open Veterinary Science Journal, 2010, Vol. 4, pp. 127-133. 16- Sørensen, G., & Jørgensen, S. S. (1996). A critical examination of some experimental variables in the 2-thiobarbituric acid (TBA) test for lipid oxidation in meat products. Zeitschrift für Lebensmittel-Untersuchung und Forschung, 202(3), 205-210. 17- Benzie, I. F., & Strain, J. J. (1996). The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical biochemistry, 239(1), 70-76. 18– Moron, M. S., Joseph W. Depierre And Bengt Mannervik. Levels Of Glutathione, Glutathione Reductase And Glutathione S-Transferase Activities In Rat Lung And Liver. Stockholm (Sweden) : Biochimica et Biophysica Acta, 1979, Vol. 582, pp. 70-71. 19- Goth, L. (1991). A simple method for determination of serum catalase activity and revision of reference range. Clinica Chimica Acta, 196(2), 143-151. 20- Haide, R. F., Ewadh, M. J., & Al-Jaff, E. H. (2015).Biochemical Evaluation of Metabolically Active Urinary Stones. 21- Padalkar, R. K., Shinde, A. V., & Patil, S. M. (2012). Lipid profile, serum malondialdehyde, superoxide dismutase in chronic kidney diseases and type 2 diabetes mellitus. Biomedical Research, 23(2), 207-210. 22- Thamilselvan, S., Khan, S. R., & Menon, M. (2003). Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urological research, 31(1), 3-9. 23- Mahmoud, R. H., Ewadh, M. J., & Al-Hamadani, K. J. (2009). Clinical Assessment of glutathione peroxidase and catalase to the status of malondialdehyde in urolithiasis. Pak J Med Sci, 25(5), 738-743. 24- Carrasco-Valiente, J., Anglada - Curado, F. J., Aguilar-Melero, P., Gonzalez-Ojeda, R., Muntane-Relat, J., Padillo-Ruiz, F. J., & Requena-Tapia, M. J. (2012). State of acute phase markers and oxidative stress in patients with kidney stones in the urinary tract. Actas Urológicas Españolas (English Edition), 36(5), 296-301. 25- Khan, S. R. (2014). Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis Translational andrology and urology, 3(3), 256. 26- Mallikarjunappa, S., & Prakash, M. (2007). Urine protein thiols in chronic renal failure patients. Indian Journal of Nephrology, 17(1), 7. 27- Taylor, E. N., Stampfer, M. J., & Curhan, G. C. (2005). Obesity, weight gain, and the risk of kidney stones. Jama, 293(4), 455-462. 28- Abdel-Halim, R. E. (2005). Urolithiasis in adults. Clinical and biochemical aspects. Saudi medical journal, 26(5), 705-713. 29- Powell, C. R., Stoller, M. L., Schwartz, B. F., Kane, C., Gentle, D. L., Bruce, J. E., & Leslie, S. W. (2000). Impact of body weight on urinary electrolytes in urinary stone formers. Urology, 55(6), 825-830. 30- Singh, D., Kaur, R., Chander, V., & Chopra, K. (2006). Antioxidants in the prevention of renal disease. Journal of medicinal food, 9(4), 443-450. 31- AL-Jaff, E. H., Smaism, M. F., & Ali, S. A.(2015). Clinical and Biochemical Study in urinary stone patients in Babylon Province.

32- Kaniaw R. K. (2013). A study of some physiological and biochemical changes in renal stone former patients, Msc thesis, Vol. 3(A), No.1,( pp.9-14). 33- Mahmoud, R. H., Ewadh, M. J., & Al-Hamadani, K. J. (2009). Roles of Malondialdehyde and Catalase in Serum of Urolithiasis. Medical Journal of Babylon, 6(1), 147-153. 34- Chen, L., Zhang, X., Hao, T., Liang, R., Man, S. Y. B., Huang, G., & Tang, S. (2016). Research progress on antioxidant activity of natural products . European Journal of Bio Medical Research, 2(1), 36-40. 35- Khan, S. R. (2013). Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. The Journal of urology, 189(3), 803-811. 36 - Prakash, M., Shetty, J. K., Dash, S., Barik, B. K., Sarkar, A., Awanti, S. M., & Prabhu, R. (2008). Urinary protein thiols in different grades of proteinuria. Indian Journal of Clinical Biochemistry, 23(4), 404-406. 37- Massey, L. K. (1995). Dietary salt, urinary calcium, and kidney stone risk. Nutrition reviews 53(5), 131-134. 38- Dhanakoti, S. N., & Draper, H. H. (1987). Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo. Lipids,22(9), 643-646.

39 - Siener, R., & Hesse, A. (2003). The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation.European journal of nutrition, 42(6), 332-337.

40- Sarıca, K., Altay, B., & Erturhan, S. (2008). Effect of being overweight on stone-forming risk factors. Urology, 71(5), 771-774. 41- Qaader, D. S., Yousif, S. Y., & Mahdi, L. K. (2006). Prevalence and etiology of urinary stones in hospitalized patients in Baghdad. 42- Tungsanga, K., Sriboonlue, P., Futrakul, P., Yachantha, C., & Tosukhowong, P. (2005). Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urological research,33(1), 65-69. 43- Thamilselvan, S., Hackett, R. L., & Khan, S. R. (1997). Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. The Journal of urology, 157(3), 1059-1063. 44- Shavit, L., Ferraro, P. M., Johri, N., Robertson, W., Walsh, S. B., Moochhala, S., & Unwin, R. (2015). Effect of being overweight on urinary metabolic risk factors for kidney stone formation Nephrology Dialysis Transplantation, 30(4), 607-613. 45- Sofia, N. H., & Walter, T. M. (2016). PREVALENCE AND RISK FACTORS OF KIDNEY STONE. Global Journal For Research Analysis, 5(3). 46- Mente, A., Honey, R. J. D. A., McLaughlin, J. M., Bull, S. B., & Logan, A. G. (2006). High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. Journal of the American Society of Nephrology, 17(9), 2567-2575.